Considering the steadily rising number of overdose deaths in recent years, public health systems rely on the vital role of medicolegal death investigation (MDI) to better understand why people are dying and to determine the best course of action to prevent future drug-related deaths. MDI offices maintain thorough documentation on these cases, but often the only information available for public health purposes is through the wording on death certificates, which is coded and transmitted through ICD-10 codes. It is difficult to fully understand the extent of the opioid epidemic without consistency in how crucial information is expressed on death certificates. Therefore, is it vital that the medical examiner or coroner who is certifying these unnatural deaths understands how the information is being translated and recognizes how to best convey the summary of an entire investigation into the condensed form of a death certificate.
This webinar will cover best practices for determining cause of death in suspected drug-related deaths, including performance of autopsy and toxicology when possible. It will also include some recommendations for when a drug-related death should be suspected based on a decedent’s history and scene findings. This webinar will dive into specifics on how drugs should be listed on the death certificate once the cause of death is established. This is especially important for deaths related to multiple drugs detected in the system and in death investigations where the cause of death is a complication of acute intoxication that might otherwise be considered a natural death (such as a stroke). Best practice recommendations on manner of death will also be covered, as will understanding the difference between including information on parts 1 and 2 of the death certificate. Information will be presented on filing death certificates with a pending cause and/or manner of death, and lastly best practice recommendations for completion of the injury information on the death certificate will be presented.